We are live on
!
Find out more
JF
Jump Financial Portfolio holdings
AUM
$7.5B
1-Year Est. Return
33.9%
This Fund
S&P 500
This Quarter
Est. Return
+5.93%
1 Year Est. Return
+33.9%
3 Year Est. Return
+69.87%
5 Year Est. Return
+55.07%
10 Year Est. Return
–
AUM
$2.71B
AUM Growth
+$256M
(+10%)
Cap. Flow
+$184M
Cap. Flow
% of AUM
6.78%
Top 10 Holdings %
Top 10 Hldgs %
6.67%
Holding
2,298
New
784
Increased
473
Reduced
488
Closed
552
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$19.5M |
| 2 |
Target
TGT
|
+$17.3M |
| 3 |
Royalty Pharma
RPRX
|
+$15.5M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$14.9M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$14.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$12.2M |
| 2 |
ProShares Short VIX Short-Term Futures ETF
SVXY
|
+$11M |
| 3 |
iShares Semiconductor ETF
SOXX
|
+$10.4M |
| 4 |
ProShares UltraPro Short QQQ
SQQQ
|
+$8.83M |
| 5 |
ProShares UltraPro S&P 500
UPRO
|
+$8.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.61% |
| 2 | Industrials | 13.75% |
| 3 | Healthcare | 12.7% |
| 4 | Consumer Discretionary | 12.54% |
| 5 | Financials | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
LeMaitre Vascular
LMAT
$2.29B
| $648K | 0.02% |
+9,638
| New | +$588K |
|
902
Hyster-Yale Materials Handling
HY
$591M
| $648K | 0.02% |
+11,601
| New | +$593K |
|
903
Otis Worldwide
OTIS
$27.3B
| $645K | 0.02% |
+7,247
| New | +$611K |
|
904
McKesson
MCK
$100B
| $644K | 0.02% |
1,508
-10,226
| -87% | -$3.93M |
|
905
First Citizens BancShares
FCNCA
$24.6B
| $642K | 0.02% |
+500
| New | +$578K |
|
906
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.8B
| $639K | 0.02% |
25,554
-5,990
| -19% | -$157K |
|
907
Shift4
FOUR
$4.16B
| $638K | 0.02% |
+9,400
| New | +$616K |
|
908
Direxion Daily Gold Miners Index Bear 2X ETF
DUST
$71.5M
| $638K | 0.02% |
+527
| New | +$558K |
|
909
Newmark Group
NMRK
$2.64B
| $637K | 0.02% |
102,371
+55,940
| +120% | +$345K |
|
910
Zegna
ZGN
$4B
| $635K | 0.02% |
+50,072
| New | +$624K |
|
911
CRISPR Therapeutics
CRSP
$4.72B
| $634K | 0.02% |
11,301
-111,258
| -91% | -$6.31M |
|
912
Kimbell Royalty Partners
KRP
$1.46B
| $634K | 0.02% |
+43,109
| New | +$666K |
|
|
DEN
913
DELISTED
Denbury Inc.
DEN
| $634K | 0.02% |
+7,346
| New | +$666K |
|
914
Winmark
WINA
$1.17B
| $632K | 0.02% |
1,902
+544
| +40% | +$184K |
|
|
AMK
915
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $632K | 0.02% |
+21,309
| New | +$626K |
|
916
Protolabs
PRLB
$1.83B
| $629K | 0.02% |
+17,991
| New | +$573K |
|
917
Viasat
VSAT
$10.5B
| $629K | 0.02% |
15,238
-33,620
| -69% | -$1.31M |
|
918
Cimpress
CMPR
$2.31B
| $628K | 0.02% |
10,563
-7,237
| -41% | -$357K |
|
919
Autodesk
ADSK
$48.4B
| $627K | 0.02% |
+3,065
| New | +$613K |
|
920
Frontdoor
FTDR
$5.07B
| $625K | 0.02% |
+19,603
| New | +$584K |
|
921
ProShares UltraPro Short Russell2000
SRTY
$81.1M
| $624K | 0.02% |
3,851
-9,011
| -70% | -$1.73M |
|
922
NeoGenomics
NEO
$2.03B
| $624K | 0.02% |
38,810
+23,443
| +153% | +$386K |
|
923
Domo
DOMO
$173M
| $623K | 0.02% |
42,488
+21,800
| +105% | +$322K |
|
924
Vanda Pharmaceuticals
VNDA
$302M
| $621K | 0.02% |
94,284
+45,184
| +92% | +$290K |
|
925
KeyCorp
KEY
$24.3B
| $620K | 0.02% |
67,149
-216,651
| -76% | -$2.26M |
|
Similar funds
YAM
ASN
SP
AMH
BIM
CCM
GJL
DKCM
Jump Financial's Q2 2023 Portfolio in Review
As of Q2 2023, Jump Financial held 2,298 positions worth $2.71B, up 10% from $2.46B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Jump Financial deployed $184M of net new capital in Q2 2023, opening 784 new positions and adding to 473 existing holdings. Its largest new stake was Royalty Pharma: 456,285 shares worth $14M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $12.2M trimmed.
- Jump Financial's largest Q2 2023 buy was Royalty Pharma: 456,285 shares worth $14M.
- Jump Financial added most to State Street Utilities Select Sector SPDR ETF in Q2 2023, an estimated $19.5M increase.
- Jump Financial's biggest Q2 2023 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $12.2M.
- Jump Financial fully exited ProShares Short VIX Short-Term Futures ETF in Q2 2023, selling an estimated $11M.
- Jump Financial's ten largest holdings make up 6.7% of its $2.71B portfolio in Q2 2023.
- Jump Financial opened 784 new positions and closed 552 in Q2 2023.
- Jump Financial's portfolio value rose 10% quarter-over-quarter to $2.71B.
Based on Jump Financial's 13F filing for Q2 2023, filed 7 Aug 2023.